Clinical Trials Browser

Phase 2 × Oligodendroglioma × Neoadjuvant Therapy × Clear all

NCT00033280 2020-10-22

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Phase 2 Completed

Glioma, Oligodendroglioma, Central Nervous System Neoplasms